SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-15-074329
Filing Date
2015-10-30
Accepted
2015-10-30 07:03:18
Documents
12
Period of Report
2015-10-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-21950_18k.htm 8-K 24590
2 EX-99.1 a15-21950_1ex99d1.htm EX-99.1 549885
3 GRAPHIC g219501mm03i001.jpg GRAPHIC 1900
4 GRAPHIC g219501mm07i001.jpg GRAPHIC 1900
5 GRAPHIC g219501mm11i001.jpg GRAPHIC 1900
6 GRAPHIC g219501mm01i001.jpg GRAPHIC 1900
7 GRAPHIC g219501mm01i002.jpg GRAPHIC 1899
8 GRAPHIC g219501mm01i003.jpg GRAPHIC 1901
9 GRAPHIC g219501mm09i001.jpg GRAPHIC 1900
10 GRAPHIC g219501mm05i001.jpg GRAPHIC 1900
11 GRAPHIC g219501mm13i001.jpg GRAPHIC 1900
12 GRAPHIC g219501mm15i001.jpg GRAPHIC 2087
  Complete submission text file 0001104659-15-074329.txt   603533
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 151185325
SIC: 2834 Pharmaceutical Preparations